
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
Departments of Leukemia [G. G-M., J. D., J. W., H. M. K., J-P. J. I.] and Hematopathology [C. B-R.], University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
Purpose: Aberrant DNA methylation of promoter-associated CpG islands is an epigenetic DNA modification observed in acute leukemias that in certain cases has been associated with a poor prognosis and increased relapse rates. To study the role of DNA methylation in relapse mechanisms in acute lymphocytic leukemia (ALL), we have compared the methylation status of five genes at the time of initial presentation and at first relapse in 25 adult patients with ALL.
Experimental Design: Genes studied included the estrogen receptor (ER), multidrug resistance gene 1 (MDR1), p73, p15, and p16. DNA was extracted from paraffin-embedded bone marrow biopsies. DNA methylation was analyzed using PCR of bisulfite-modified DNA.
Results: Results indicate that methylation at the time of relapse was stable in 92% of patients for p73, 88% for ER, 80% for p16, 72% for MDR1, and 60% for p15. Only one case had p16 methylation at initial presentation, whereas 6 patients (P = 0.0001) had methylation at relapse. Three cases had concomitant methylation of p15 and p16 at relapse. The degree of MDR1 methylation inversely correlated with the presence of MDR1 expression as detected by immunohistochemistry. Eighteen patients (72%) had acquired no or one methylation change, whereas the rest (28%) had methylation changes in two or three genes. No clinical-biological correlations were found between methylation of any particular gene or pattern.
Conclusions: In summary, DNA methylation patterns are stable in a majority of patients with relapsed ALL, but a subset of patients acquire new methylation changes, in particular affecting cell cycle regulatory genes.
This article has been cited by other articles:
![]() |
A. Scuto, M. Kirschbaum, C. Kowolik, L. Kretzner, A. Juhasz, P. Atadja, V. Pullarkat, R. Bhatia, S. Forman, Y. Yen, et al. The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells Blood, May 15, 2008; 111(10): 5093 - 5100. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bueso-Ramos, Y. Xu, T. J. McDonnell, S. Brisbay, S. Pierce, H. Kantarjian, G. Rosner, and G. Garcia-Manero Protein Expression of a Triad of Frequently Methylated Genes, p73, p57Kip2, and p15, Has Prognostic Value in Adult Acute Lymphocytic Leukemia Independently of Its Methylation Status J. Clin. Oncol., June 10, 2005; 23(17): 3932 - 3939. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hoshino, H. Yang, B. Sanchez-Gonzalez, and G. Garcia-Manero Detection of Aberrant DNA Methylation in Acute Lymphocytic Leukemia (ALL) Using a Real-Time Polymerase Chain Reaction (PCR) Assay. Blood (ASH Annual Meeting Abstracts), November 16, 2004; 104(11): 998 - 998. [Abstract] |
||||
![]() |
S. S. Liu, R. C.-Y. Leung, K. Y.-K. Chan, P.-M. Chiu, A. N.-Y. Cheung, K.-F. Tam, T.-Y. Ng, L.-C. Wong, and H. Y.-S. Ngan p73 Expression Is Associated with the Cellular Radiosensitivity in Cervical Cancer after Radiotherapy Clin. Cancer Res., May 15, 2004; 10(10): 3309 - 3316. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zheng, X. Ma, L. Zhang, L. Gunn, M. T. Smith, J. L. Wiemels, K. Leung, P. A. Buffler, and J. K. Wiencke Hypermethylation of the 5' CpG Island of the FHIT Gene Is Associated with Hyperdiploid and Translocation-Negative Subtypes of Pediatric Leukemia Cancer Res., March 15, 2004; 64(6): 2000 - 2006. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shen, M. Toyota, Y. Kondo, T. Obata, S. Daniel, S. Pierce, K. Imai, H. M. Kantarjian, J.-P. J. Issa, and G. Garcia-Manero Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia Blood, May 15, 2003; 101(10): 4131 - 4136. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. El-Osta, M. Lubbert, P. W. Wijermans, T. Licht, and P. A. Jones On the use of DNA methylation inhibitors and the reversal of transcriptional silencing Blood, February 15, 2003; 101(4): 1656 - 1657. [Full Text] [PDF] |
||||
![]() |
L. Shen, Y. Kondo, J.-P. Issa, G. Garcia-Manero, J. Roman-Gomez, J. A. Castillejo, A. Torres, and A. Jimenez Lack of p21CIP1 DNA methylation in acute lymphocytic leukemia Blood, October 16, 2002; 100(9): 3432 - 3433. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |